NEUE icon

NeueHealth

6.57 USD
+0.08
1.23%
Updated Aug 26, 3:07 PM EDT
1 day
1.23%
5 days
-0.45%
1 month
-2.95%
3 months
-3.52%
6 months
-10.61%
Year to date
-10.37%
1 year
34.08%
5 years
-99.51%
10 years
-99.51%
 

About: NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.

Employees: 986

0
Funds holding %
of 7,433 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 39 [Q1] → 40 (+1) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 5 [Q1] → 5 (+0) [Q2]

2.16% less ownership

Funds ownership: 61.16% [Q1] → 59.0% (-2.16%) [Q2]

8% less capital invested

Capital invested by funds: $39.6M [Q1] → $36.3M (-$3.3M) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for NEUE.

Financial journalist opinion

Neutral
Seeking Alpha
2 weeks ago
NeueHealth, Inc. (NEUE) Q2 2025 Earnings Call Transcript
NeueHealth, Inc. (NYSE:NEUE ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Emily Lombardi - Corporate Participant George Lawrence Mikan - Vice Chairman, CEO & President Jay Stephen Matushak - Chief Financial Officer Operator Good morning. Thank you for attending today's conference call.
NeueHealth, Inc. (NEUE) Q2 2025 Earnings Call Transcript
Neutral
Business Wire
2 weeks ago
NeueHealth Reports Second Quarter 2025 Results
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2025. “We are pleased to report another strong quarter of financial results as we continue to build on the momentum we have established across our business this year,” said Mike Mikan, President and CEO of NeueHealth. “We delivered our sixth consecutive quarter of Adjusted EBITDA profitability, an.
NeueHealth Reports Second Quarter 2025 Results
Neutral
Business Wire
1 month ago
NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report second quarter financial results before the financial markets open on Thursday, August 7, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in num.
NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025
Neutral
Seeking Alpha
3 months ago
NeueHealth, Inc (NEUE) Q1 2025 Earnings Call Transcript
NeueHealth, Inc (NYSE:NEUE ) Q1 2025 Results Conference Call May 8, 2025 8:00 AM ET Company Participants Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Operator Good morning, and welcome to NeueHealth's First Quarter 2025 Earnings Conference Call. As a reminder, this call is being recorded.
NeueHealth, Inc (NEUE) Q1 2025 Earnings Call Transcript
Neutral
Business Wire
3 months ago
NeueHealth Reports First Quarter 2025 Results
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. “We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another quarter of Adjusted EBITDA profitability,” said Mike Mikan, President and CEO of NeueHealth. “Our value-driven, consumer-centric care model is compelling,.
NeueHealth Reports First Quarter 2025 Results
Neutral
Business Wire
4 months ago
NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number,.
NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025
Neutral
Business Wire
4 months ago
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NeueHealth, Inc. (NYSE: NEUE) to an affiliate of New Enterprise Associates. Under the terms of the proposed transaction, shareholders of NeueHealth will receive $7.33 in cash for each share of NeueHealth that they own. KSF is seeking to determine whether this consideration and the process that led to it are ad.
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE
Neutral
Seeking Alpha
5 months ago
NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript
NeueHealth, Inc (NYSE:NEUE ) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Operator Good morning, and thank you for joining us for the NeueHealth Q4 2024 Earnings Conference Call. My name is Carlin.
NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript
Neutral
Business Wire
5 months ago
NeueHealth Reports Fourth Quarter and Full Year 2024 Results
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. “In 2024, we delivered our strongest financial performance to date, demonstrating the power of our value-driven, consumer-centric care model,” said Mike Mikan, President and CEO of NeueHealth. “We have established a strong foundation to drive strategic growth in 2025 with a.
NeueHealth Reports Fourth Quarter and Full Year 2024 Results
Neutral
Business Wire
5 months ago
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report fourth quarter and full year 2024 financial results before the financial markets open on Thursday, March 20, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, in.
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025
Charts implemented using Lightweight Charts™